Wegovy Cost: With Insurance, Without, and the Savings Offer

Wegovy is one of the few drugs where the manufacturer publishes its own cash prices, so you do not have to guess. The problem is that most pages quoting "Wegovy cost" are running on numbers from a prior offer cycle, and almost none of them cover the tablets. Below is the full published ladder for both forms, transcribed from Novo Nordisk's own price guide, with the dates the offers expire.

Wegovy Cost Without Insurance: The NovoCare Self-Pay Prices

The number that scares people is the list price. Novo publishes it as $1,349.02 per package — and it is the same $1,349.02 whether you are looking at the Wegovy pen, the Wegovy HD pen, or the Wegovy tablets. That is the pre-rebate sticker, not what a cash payer is asked to pay.

What a cash payer is actually asked to pay is published separately, as the NovoCare Pharmacy self-pay price. Novo runs its own pharmacy that ships direct, and it prints the price by dose. Here is the pen ladder as published:

Two details in Novo's footnotes matter more than the headline. First, "one month" is defined as one box of four pens — so the monthly price is a four-week supply, not a calendar month of flexibility. Second, the $199 intro price applies to two monthly fills only, for patients new to the Wegovy Savings Offer and NovoCare Pharmacy, through December 31, 2026. After that the published price is $349/mo. Budget against $349, not $199.

Wegovy Pill Cost: What the Tablets Run

This is the part almost no competing cost page has caught up to. Wegovy is now available as a once-daily tablet in addition to the weekly injection, and Novo publishes a completely separate self-pay price ladder for it. Per the FDA label, Wegovy tablets are supplied in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths.

Novo defines one month of tablets as one bottle of 30. Note what the ladder does: the price rises with strength, from $149 to $299. So "the Wegovy pill starts at $149" is accurate and also incomplete — $149 is the entry strength, and the published price at the top of the ladder is roughly double that.

One compliance point worth stating plainly, because search results blur it constantly: Wegovy tablets are not Rybelsus. Both are oral semaglutide, but they are different products with different approved uses — Rybelsus is indicated for type 2 diabetes, while Wegovy tablets are indicated for chronic weight management and cardiovascular risk reduction. Wegovy is also not Ozempic, which is the type 2 diabetes injection. Same molecule, different products, different labels, different prices. Our GLP-1 medications list maps every brand to its approved indication, and the GLP-1 pill guide compares the oral options side by side.

The Wegovy Manufacturer Coupon: Read the Cap

Search "Wegovy coupon" and you will get thousands of pages promising $25. Here is the actual published term, in Novo's own words: "Pay as little as $25, subject to a maximum savings of $100/month." That applies to all doses of both the pen and the pill, for people with commercial insurance that covers Wegovy.

The two halves of that sentence pull in opposite directions, and the second half is the one that governs. The card reduces your copay by up to $100 per month. If your plan leaves you a $125 copay, the card can bring you to $25. If your plan leaves you a $400 copay, the card brings you to $300 — not $25. "As little as" is a floor you reach only if your copay was already close to it.

The savings offer has a second half that gets much less coverage. If you are uninsured or paying cash, the same program routes you to NovoCare Pharmacy self-pay pricing instead of a copay reduction — the ladders in the two tables above. Novo states savings are available to people using commercial insurance or those who are uninsured or self-paying with a valid prescription, and that you must be a U.S. resident to sign up.

Everything here is a description of published program terms as of August 21, 2026. We are not affiliated with Novo Nordisk, we cannot enroll you, and we are not promising you will qualify or save. Novo states it reserves the right to modify or cancel the program at any time.

Wegovy Pill Coupon vs Wegovy Tablet Coupon

These are the same thing, and there is no tablet-specific coupon separate from the injection coupon. Both forms run through the one Wegovy Savings Offer. What differs is which side of the program you land on:

The practical read: on the copay side the two forms cost the same (same $25 floor, same $100 cap), and on the cash side the pill is the cheaper published product at every rung of its ladder. Whether the pill is the right form for you is a clinical question, not a pricing one.

NovoCare Wegovy: What the Channel Actually Is

"NovoCare Wegovy" is a high-volume search, and it usually means one of two things:

• NovoCare, the support program. Novo Nordisk's patient-support arm, which publishes the Wegovy Savings Offer terms, the coverage explainers, and the price guide the tables above come from.
• NovoCare Pharmacy, the direct pharmacy. A manufacturer-operated pharmacy that fills and ships Wegovy to cash-paying patients at the published self-pay prices. Novo states its self-pay pricing is available for home delivery or, with a savings offer, local pharmacy pickup.

What it is not is a third-party discount-card marketplace or a telehealth clinic. You still need a valid prescription from a licensed prescriber, and NovoCare does not prescribe for you. If you do not already have a prescriber, that is the step that comes first — our GLP-1 program comparison and the weight-loss clinic directory cover the prescribing side.

Wegovy Cost With Insurance

There is no honest single number here, and any page that gives you one is guessing. Commercial coverage for Wegovy varies more than for almost any other drug class. What we can describe accurately is the shape of the variation:

• Some plans exclude weight-management drugs entirely. This is a plan-design choice, not a clinical one, and it is common enough that it should be the first thing you check on your formulary.
• Prior authorization is routine. Plans that do cover Wegovy commonly require documentation before approving it, and some require a step-therapy trial of another agent first.
• The indication you are prescribed under can change the answer. Wegovy injection carries an FDA-approved indication to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight — alongside its chronic weight-management indication. Some plans that exclude weight-loss drugs will still cover it under the cardiovascular indication. This is a conversation for your prescriber, who determines which indication applies to you.
• The copay card sits on top. If the plan covers it, the savings offer reduces what is left by up to $100/month.

For completeness on the label: per the prescribing information, Wegovy injection is indicated for cardiovascular risk reduction, for weight reduction in adults and in pediatric patients aged 12 and older with obesity, for adults with overweight plus at least one weight-related condition, and — under accelerated approval — for noncirrhotic MASH with moderate to advanced liver fibrosis in adults. Wegovy tablets carry a narrower set: cardiovascular risk reduction and weight reduction in adults, without the pediatric or MASH indications. If coverage hinges on indication, that difference between the two forms can matter.

Medicare, Medicaid, and Government Insurance

The manufacturer copay card is not available to you. Novo's footnote is one sentence: "Government beneficiaries excluded." That covers Medicare and Medicaid. This is not a Novo quirk — federal anti-kickback rules generally bar manufacturer copay assistance for patients in federal healthcare programs, which is why nearly every drug coupon carries the same exclusion.

Two published carve-outs are worth knowing:

• You can still pay the self-pay price. Novo states that government-insured patients may use the program if they self-pay and process the prescription outside of their insurance. You give up any plan benefit, but you get the NovoCare cash ladder.
• FEHB, exchange plans, and state employee plans are not treated as government programs here. Novo states explicitly that the Federal Employees Health Benefits Program, health-exchange (ACA) plans, and state employee plans are not federal or state government healthcare programs for purposes of this savings offer — so those members are not swept into the exclusion.

Separately, Novo launched the Medicare GLP-1 Bridge on July 1, 2026, offering eligible Medicare beneficiaries a $50 monthly copay for Wegovy — covering both the injection and the pill — currently set to run through December 31, 2027. Eligibility conditions apply and the program is administered separately from your Part D plan. Confirm your eligibility with NovoCare and your plan rather than assuming it.

Cheaper Routes to Semaglutide

Brand Wegovy at $149–$399/mo is one option among several, and it is not always the cheapest. The trade-offs are real in both directions — brand product has an FDA label behind it, while cheaper routes vary in what they include and how they are regulated. These guides cover the alternatives honestly:

• Clinic program pricing: our semaglutide cost guide tracks verified monthly prices at clinics that publish them, tagged for whether the medication is included
• The cheapest overall path: cheapest GLP-1 without insurance compares across molecules and brands, not just Wegovy
• Semaglutide specifically: the cheapest way to get semaglutide walks the routes in price order
• Compounded versions: compounded semaglutide explains what compounding is, what it costs, and what the FDA has said about it
• Every approved option: the complete GLP-1 medications list maps brand to molecule to approved indication
• Oral options compared: the GLP-1 pill guide covers every FDA-approved oral GLP-1 side by side
• Cross-service pricing: the cash-pay price index tracks published prices across categories

Things to Know Before You Fill

• Offers here are dated and they expire. The 4 mg tablet price changes August 31, 2026; the $199 pen on-ramp ends after two fills or December 31, 2026. Re-check before you budget.
• "One month" is a defined quantity. One box of four pens, or one bottle of 30 tablets. Compare like for like.
• Price rises with tablet strength. The pill ladder runs $149 to $299/mo, so an entry price is not a maintenance price.
• The copay card is capped at $100/month. It reduces a copay; it does not set one.
• A prescription is required either way. NovoCare Pharmacy fills prescriptions; it does not write them.
• Wegovy, Ozempic, and Rybelsus are different products. Same molecule, different approved uses and prices. Do not price one from another.
• Prices change without notice. Every figure here was verified August 21, 2026 against Novo's published materials, and Novo states it can modify or cancel the program at any time.